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OBJECTIVE: This report reviews the evidence for ad-
verse effects of diabetes on periodontal health and peri-
odontal disease on glycemic control and complications of
diabetes.
DESIGN: MEDLINE search of the English language litera-
ture identified primary research reports published on (a)
relationships between diabetes and periodontal diseases
since 2000 and (b) effects of periodontal infection on gly-
cemic control and diabetes complications since 1960.
RESULTS: Observational studies provided consistent
evidence of greater prevalence, severity, extent, or pro-
gression of at least one manifestation of periodontal
disease in 13/17 reports reviewed. Treatment and longi-
tudinal observational studies provided evidence to sup-
port periodontal infection having an adverse effect on
glycemic control, although not all investigations reported
an improvement in glycemic control after periodontal
treatment. Additionally, evidence from three observa-
tional studies supported periodontal disease increasing
the risk for diabetes complications and no published
reports refuted the findings.
CONCLUSION: The evidence reviewed supports diabe-
tes having an adverse effect on periodontal health and
periodontal infection having an adverse effect on glyce-
mic control and incidence of diabetes complications.
Further rigorous study is necessary to establish unequiv-
ocally that treating periodontal infections can contribute
to glycemic control management and to the reduction of
the burden of diabetes complications.
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Introduction
Diabetes mellitus and periodontal disease are two
common chronic diseases that have long been consid-
ered to be biologically linked. Diabetes is an important
chronic disease globally as reflected in the World
Health Organization (WHO) declaring the rate of
increase in diabetes prevalence is an epidemic. The
WHO estimated there were 30 million people who had
diabetes worldwide in 1985. This number increased to
135 million by 1995, and reached 217 million in 2005.
By 2030 WHO predicts this number to increase to at
least 366 million (Smyth and Heron, 2006). This
growth in diabetes prevalence, driven principally by
increasing prevalence of type 2 diabetes, is occurring in
both developing and developed countries. The two
countries with the largest predicted increases are India
and China and the US ranked third (Smyth and Heron,
2006).
Susceptible individuals with diabetes and those with
chronically poor metabolic control can experience
microvascular and macrovascular complications leading
to a significant burden for the individual and society.
This burden includes direct costs of medical care and
indirect costs, such as lost productivity, which result
from diabetes-related morbidity and premature mortal-
ity (Harris, 1995; Hogan et al, 2003). Health care
spending for people with diabetes is more than double
what spending would be without diabetes, and direct
and indirect expenditures attributable to diabetes in
2002 in the US were conservatively estimated at $132
billion, with slightly more spent on chronic complica-
tions attributable to diabetes than on diabetes care itself
(Hogan et al, 2003). The International Diabetes Feder-
ation estimated that diabetes accounts for 5–10% of the
total healthcare budget in many countries (Smyth and
Heron, 2006).
Gingivitis and periodontitis are the most common
periodontal diseases. For example, in the US approxi-
mately 50% of the population in all age groups exhibit
reversible gingival inflammation (Albandar and King-
man, 1999). Moderate or severe periodontitis, with
destruction of periodontal attachment tissues is much
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less common than gingivitis yet still a common chronic
disease, affecting approximately 5–15% of any popula-
tion (Albandar et al, 1999; Burt, 2005).
Current evidence regarding the biologic link between
diabetes and periodontal disease supports diabetes and
persisting hyperglycemia leading to an exaggerated
immuno-inflammatory response to the periodontal
pathogenic bacterial challenge (Southerland et al,
2006; Nishimura et al, 2007), resulting in more rapid
and severe periodontal tissue destruction. In the meta-
bolic dysregulation of diabetes, persisting hyperglycemia
causes non-enzymatic glycation and oxidation of pro-
teins and lipids, and the subsequent formation of
advanced glycation endproducts (AGEs), which accu-
mulate in the plasma and tissues (Brownlee, 1994;
Schmidt et al, 1996b; Ramasamy et al, 2005). Hyper-
glycemia and resultant AGE formation are considered
to be a major causal factor in the pathogenesis of
diabetes complications (Brownlee, 1994; Vlassara,
1994). In subjects with diabetes who also have peri-
odontitis, AGEs with accompanying markers for
increased oxidant stress have been demonstrated in
human gingiva (Schmidt et al, 1996a). Cell surface
binding sites or receptors for AGE (RAGE) have been
identified on the cell surfaces of several cell types
exhibiting a heightened inflammatory response and
involved with the pathogenesis of complications of
diabetes. These cell types include mononuclear phago-
cytes, endothelial cells, fibroblasts, smooth muscle cells,
lymphocytes, podocytes, and neurons (Brett et al, 1993;
Ramasamy et al, 2005). The receptor for AGEs, RAGE,
is the principal signal transducer for the AGE ligand
(Schmidt et al, 2000).
The underlying postulate associated with these find-
ings is that enhanced oxidant stress in the gingival
tissues could contribute to more frequent and more
severe periodontal tissue destruction in individuals with
diabetes. For example, it has been hypothesized that the
AGE-RAGE interaction induces an oxidant stress that
may contribute to chronic monocytic upregulation,
activation of NF-jB, and subsequent expression of
mRNA and secretion of proinflammatory cytokines
(such as TNF-a, IL-1b, and IL-6) by monocytic
phagocytes involved in periodontal tissue inflammation
and destruction (Baeuerle, 1991; Schreck et al, 1991;
Moughal et al, 1992; Collins, 1993; Schmidt et al, 1994,
1996a; Takahashi et al, 1994; Yan et al, 1994). These
mediators are recognized as effectors in periodontal
tissue inflammation and destruction (Salvi et al, 1998).
Blockade of RAGE has been shown to diminish
Porphyromonas gingivalis-triggered alveolar bone loss
in the periodontium and limit the enhanced inflamma-
tory response in peripheral wounds, accelerating wound
closure and facilitating angiogenesis (Lalla et al, 2000;
Goova et al, 2001). Additionally, AGE interaction with
endothelial cell RAGE has been shown to enhance
endothelial cell vascular hyperpermeability and expres-
sion of vascular cell adhesion molecule-1, an adherence
molecule capable of attracting mononuclear cells to the
vascular wall (Schmidt et al, 1995; Wautier et al, 1996;
Lalla et al, 1998b). Hence, AGE-RAGE interaction has
been proposed to result in pertubation of cellular
properties, exaggerated and sustained inflammatory
response, impaired wound healing, and more severe
diabetes-associated periodontal disease (Lalla et al,
1998a).
The specific ways in which diabetes-enhanced inflam-
mation and apoptosis may specifically impact on peri-
odontal tissues of was recently thoroughly reviewed
(Graves et al, 2006). In their review, Graves and
colleagues describe that diabetes has been reported to
adversely affect bone repair by decreasing expression of
genes that induce osteoblast differentiation, and dimin-
ishing growth factor and extracellular matrix production
(Bouillon, 1991; Kawaguchi et al, 1994; Lu et al, 2003).
One proposed mechanism for these adverse effects is
through the contribution of AGEs to decreased extra-
cellular matrix production and inhibition of osteoblast
differentiation (McCarthy et al, 2001; Cortizo et al,
2003; Santana et al, 2003). AGEs may also delay
wound-healing by inducing apoptosis of extracellular-
matrix-producing cells. This enhanced apoptosis would
reduce the number of osteoblastic and fibroblastic cells
available for the repair of resorbed alveolar bone
(Graves et al, 2006). In addition to promoting apopto-
sis, AGEs could affect oral tissue healing by reducing
expression of collagen and promoting inflammation.
The mechanisms suggested for AGE-enhanced apopto-
sis include the direct activation of caspase activity, and
indirect pathways that increase oxidative stress or the
expression of pro-apoptotic genes that regulate apopto-
sis (Graves et al, 2006).
Diabetes mellitus and its effects on
periodontal disease
Evidence establishing the link between diabetes mellitus
and adverse effects on periodontal health have been
extensively reviewed (Taylor, 2001; Mealey et al, 2006).
In a narrative review of the English language literature
published between 1960 and 2000 Taylor (2001)
reported that 44 of 48 observational studies provided
supportive evidence of diabetes adversely affecting
periodontal health provided (37 of the 41 cross-sectional
and seven of the seven cohort studies).
The review conducted for this current report extends
that 2001 review to include reports published into 2007.
The search used MEDLINE as well as reviewed
reference lists of relevant papers obtained from the
search to identify primary research reports on investi-
gations of relationships between diabetes/diabetes con-
trol and periodontal diseases/periodontal treatment.
While the literature review is extensive in conducting
the MEDLINE search, it is not exhaustive in that no
other databases were searched. This review does not
provide a formal assessment of the quality of the
reports. The reports identified are displayed in table-
form and the corresponding description is organized
according to the following groupings of studies: (1) The
effects of having diabetes on periodontal diseases in
studies that include a non-diabetes comparison group
(Table 1) and (2) Effect of the degree of glycemic
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control, usually measured by level of glycosylated
hemoglobin, on periodontal status in studies that
included assessment of degree of glycemic control while
evaluating periodontal status in participants with dia-
betes (Table 2).
The reports included in Table 1 were restricted to
studies which compared periodontal health in subjects
with and without diabetes. This subject has attracted
increasing attention with greater numbers of publica-
tions in consecutive decades, ranging from six in the
1960s, eight in the 1970s, and 12 in the 1980s to 20 in the
1990s. This review identified 17 reports published in
the current decade starting in the year 2000. Table 1
presents a summary of the evidence on the relationship
between diabetes and periodontal disease. Studies were
broadly classified and ordered by type of diabetes and
Table 1 Effects of diabetes on periodontal diseases in studies including a non-diabetes control group; ordered by diabetes type and subject age
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aDM type = diabetes type: 1 = type 1 diabetes mellitus; 2 = type 2 diabetes mellitus; 1,2 = both subjects with type 1 and type 2 diabetes mellitus
included; GDM = gestational diabetes mellitus; 9 = diabetes type not specified and not clearly ascertainable from other information in the report.
bAges: subjects’ ages presented as minimum – maximum reported for those with a. diabetes (DM) and b. controls (Control) unless otherwise
specified.
cMeasure of periodontal disease status: Measures used include Ging = gingivitis or gingival bleeding, Ppd = probing pocket depth, Lpa = loss of
periodontal attachment, XRBL = radiographic bone loss, JPS = juvenile periodontal score, MGI = modified gingival index, PI = Russell’s
Periodontal Index, PDR = periodontal disease rate (proportion of teeth affected by periodontal disease). The number following the measure
corresponds to greater disease in those with diabetes (1) or no difference between those with diabetes and controls (0). The letters following the
number correspond to the parameter(s) assessed in the study: e = extent, i = incidence, p = prevalence, s = severity, r = progression.
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age of subjects (Table 1). In contrast to seven reports of
prospective studies published prior to 2000, all of the
studies identified for this review are cross-sectional
and thus limited in their ability to provide evidence for
causal inferences. There was one study of type 1 diabetes
and it reported more extensive radiographic bone loss
in participants with type 1 diabetes (Tervonen et al,
2000).
Regarding the relationship between type 2 diabetes
and periodontitis the review identified 10 reports. One
report comprised 15–45+ year olds (Endean et al, 2004),
and nine (Sandberg et al, 2000; Orbak et al, 2002; Tsai
et al, 2002; Zielinski et al, 2002; Lu and Yang, 2004;
Campus et al, 2005; Chuang et al, 2005; Borges-Yáñez
et al, 2006; Mattout et al, 2006) included only adults.
Seven of these 10 studies reported significantly poorer
periodontal health in subjects with type 2 diabetes,
whereas no significant difference was discerned in a study
of mostly older Taiwanese dialysis patients with and
without insulin-dependent (type II) diabetes’ (Chuang
et al, 2005) as well as in a study of U. S. university clinic
patients 60+ years of age with good medical and dental
care comparing well-controlled (mean HbA1c = 7.3%
with 70% having HbA1c > 7.5%) subjects with diabe-
tes to subjects without diabetes (Zielinski et al, 2002);
whereas in a study of Mexicans 60+ years of age there
was a marginally significantly greater prevalence
(P = 0.09) of periodontitis in the group with diabetes
(61.5%) than in the group without diabetes (49.5%)
(Borges-Yáñez et al, 2006).
Several reports consist of analyses in which subjects
with type 1 and type 2 diabetes were not distinguished.
All of the studies in this subset were cross-sectional. One
study included children only (Lalla et al, 2007), and all
other studies included adult subjects, although one also
included children or adolescents (Arrieta-Blanco et al,
2003). Two of these three studies reported greater
prevalence, extent, or severity of periodontal disease
for at least one measure or index of periodontal disease
(Arrieta-Blanco et al, 2003; Lalla et al, 2007). One
report did not find significant differences in periodontal
disease between subjects with and without diabetes
(Ogunbodede et al, 2005).
Two studies report on analyses on National Health
and Nutrition Examination Survey III data from over
4000 women with a history of gestational diabetes
(GDM) in the US. One report included ages 15–44
(Xiong et al, 2006) the other ages 20–59 (Novak et al,
2006). Both reports concluded there is a strong rela-
tionship between GDM and periodontal disease. Xiong
et al (2006) found periodontitis in 45% of pregnant
women with GDM vs 13% in the group without
diabetes, with an adjusted odds ratio of 9.11. In non-
pregnant women, 40% of women with type 1 or 2
diabetes, 25% of those with a history of GDM, and
14% of women without diabetes had periodontal
disease. The odds ratio for those with type 1 and 2
diabetes was 2.76 (Xiong et al, 2006).Novak et al (2006)
found the prevalence of periodontal disease to be higher
in women with a history of GDM and concluded that
women with at history of GDM may be at greater risk
for developing more severe periodontal disease. A
smaller Greek study of 34–36 weeks pregnant women
also concluded gingival inflammation was more pre-
valent in the women with GDM (Mittas et al, 2006), but
also found more plaque in that group.
Table 2 Effect of degree of glycemic control on periodontal status, ordered by level of evidence, diabetes type, and subject age





Karikoski and Murtomaa (2003) Finland Prospective 1, 2, other Adults 0 No II-2
Tervonen et al (2000) Finland Cross-sectional 1 Adults 1 Yes III
Sandberg et al (2000) Sweden Cross-sectional 2 Adults 0 Yes III
Tsai et al (2002) USA Cross-sectional 2 Adults 1 Yes III
Lu and Yang (2004) Taiwan Cross-sectional 2 Adults 1 Yes III
Campus et al (2005) Italy Cross-sectional 2 Adults 1 Yes III
Chuang et al (2005) Taiwan Cross-sectional 2 Adults 0 No III
Peck et al (2006) South Africa Cross-sectional 2 Adults 1 No III
Jansson et al (2006) Sweden Cross-sectional 2 Adults 1 No III
Arrieta-Blanco et al (2003) Spain Cross-sectional 1, 2 Mixed ages 0 Yes III
Guzman et al (2003) USA Cross-sectional 1, 2* Adults 1 No III
Negishi et al (2004) Japan Cross-sectional 1, 2*,d Adults 1 No III
aHierarchy of evidence based on classification scheme used (U.S. Preventive Services Task Force, 1996) where: I = evidence obtained from at least
one properly randomized controlled trial; II-1 = evidence obtained from well-designed controlled trial without randomization; II-2 = evidence
obtained from well-designed cohort or case-control analytic studies, preferably from more than one center or research group; II-3 = evidence
obtained from multiple time series with or without the intervention. Dramatic results in uncontrolled experiments (such as the results of the
introduction of penicillin treatment in the 1940s) could also be regarded as this type of evidence; III = opinions of respected authorities, based on
clinical experience; descriptive studies and case reports; or reports of expert committees.
bDiabetes type: 1 = type 1 diabetes mellitus; 2 = type 2 diabetes mellitus; 1,2 = both subjects with type 1 and type 2 diabetes mellitus included;
GDM = gestational diabetes mellitus; 9 = diabetes type not specified and not clearly ascertainable from other information in the report;
*= diabetes type not specified but ascertained by reviewers from other information in the report or from other sources, such as direct
communication with the authors.
cEffect: 1 = subjects with poorer glycemic control had poorer health than the comparison group(s); 0 = no difference in the periodontal health
status between subjects with poorer glycemic control and comparison group(s).
dDiabetes types are 1 and 2 for all but one subject who had drug-induced diabetes mellitus.
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As with other complications of diabetes, current
evidence also supports poorer glycemic control contrib-
uting to poorer periodontal health. Primary research
reports in the literature published since 2000 investigat-
ing relationships between glycemic control level and
periodontal disease have included studies with subjects
with type 1 diabetes exclusively (one study), type 2
diabetes exclusively (seven studies), or a combination of
individuals with either type 1 or type 2 diabetes (three
studies) (Table 2). Only seven of the 12 reports pub-
lished regard the association between degree of glycemic
control and periodontal disease specifically in type 2
diabetes (Sandberg et al, 2000; Tsai et al, 2002; Lu and
Yang, 2004; Campus et al, 2005; Chuang et al, 2005;
Jansson et al, 2006; Peck et al, 2006). Five of the latter
found poorer glycemic control to be a significant factor
associated with poorer periodontal health, the associa-
tion was borderline significant in one study of dialysis
patients (Chuang et al, 2005) and no difference was
found in the remaining study (Sandberg et al, 2000).
Among the studies providing information on differences
in periodontal health classified by glycemic control
status, most have been cross-sectional, with eight of 12
publications reporting more prevalent or more severe
periodontal disease in those with poorer glycemic
control (Tervonen et al, 2000; Tsai et al, 2002; Guzman
et al, 2003; Lu and Yang, 2004; Negishi et al, 2004;
Campus et al, 2005; Jansson et al, 2006; Peck et al,
2006) and four reporting no differences (Sandberg et al,
2000; Arrieta-Blanco et al, 2003; Karikoski and
Murtomaa, 2003; Chuang et al, 2005). There was one
follow-up study identified (evidence level II-2) that was
published since 2000 (Karikoski and Murtomaa, 2003).
The preponderance of studies included in this review
of reports published since 2000 on the adverse effects of
diabetes on periodontal health are cross-sectional and
describe findings of convenience samples, principally
from outpatients in hospitals and clinics. While limita-
tions on causal inference must be considered, these
reports continue to support previous consistent evidence
of greater prevalence, severity or extent of at least one
manifestation of periodontal disease in the large major-
ity of studies. The reports reviewed also provide
additional evidence to support a dose-response’ rela-
tionship, i.e., as glycemic control worsens, the adverse
effects of diabetes on periodontal health become greater.
Further, focused study of the relationship between
gestational diabetes and periodontal health is emerging
in body of literature.
Finally, the findings and conclusions from this review
are consistent with two published meta-analyses that
have provided quantitative summaries of the adverse
effects of diabetes on periodontal health (Papapanou,
1996; Khader et al, 2006).
Periodontal disease: its effects on glycemic
control and complications of diabetes mellitus
In addition to the substantial evidence demonstrating
diabetes as a risk factor for poor periodontal health,
there is a growing body of evidence supporting
periodontal infection adversely affecting glycemic con-
trol in diabetes and contributing to increased risk for
the pathogenesis of diabetes complications. Because of
the high vascularity of the inflamed periodontium, this
inflamed tissue may serve as an endocrine-like source
for TNF-a and other inflammatory mediators
(Offenbacher et al, 1996; Grossi and Genco, 1998).
Because of the predominance of Gram-negative anaer-
obic bacteria in periodontal infection, the ulcerated
pocket epithelium is thought to constitute a chronic
source of systemic challenge from bacteria, bacterial
products and locally produced inflammatory media-
tors. TNF-a, IL6, and IL1, all mediators important in
periodontal inflammation, have been shown to have
important effects on glucose and lipid metabolism,
particularly following an acute infectious challenge or
trauma (Feingold et al, 1989; Ling et al, 1995; Grossi
and Genco, 1998). TNF-a has been reported to
interfere with lipid metabolism and to be an insulin
antagonist (Grunfeld et al, 1990; Feingold and Grun-
feld, 1992). IL6 and IL1 have also been reported to
antagonize insulin action (Ling et al, 1995; Michie,
1996; Pickup et al, 1997).
More direct, empirical evidence regarding the effects of
periodontal infection on glycemic control of diabetes
comes from treatment studies using non-surgical peri-
odontal therapy and observational studies (Table 3). The
treatment studies are a heterogeneous set of reports that
include randomized clinical trials (RCTs) and non-
RCTs. The RCTs used control groups that were either
non-treated controls (Aldridge et al, 1995; Kiran et al,
2005), positive controls (Grossi et al, 1997; Rodrigues
et al, 2003; Skaleric et al, 2004), or controls advised to
continue with their usual source of dental care (Jones
et al, 2007). Of the seven RCTs, four reported a beneficial
effect for periodontal therapy (Grossi et al, 1997; Rodri-
gues et al, 2003; Skaleric et al, 2004; Kiran et al, 2005).
An important source of variation in the RCTs is the
use of adjunctive antibiotics with the non-surgical
periodontal therapy. Among the RCTs, four included
adjunctive antibiotics used systemically (Grossi et al,
1997; Rodrigues et al, 2003; Jones et al, 2007) or
delivered locally (Skaleric et al, 2004). Three of these
four RCTs using antibiotics showed beneficial effects on
glycemic control (Grossi et al, 1997; Rodrigues et al,
2003; Skaleric et al, 2004). However, it is important to
note the significant improvement for one study was in
the positive control group that did not receive the
systemic antibiotic (Rodrigues et al, 2003) and one of
the four RCTs reporting a beneficial effect did not use
antibiotics (Kiran et al, 2005). Hence, to date there is no
clear-cut evidence to support a requirement for the use
of antibiotics in combination with non-surgical peri-
odontal treatment in order to observe an improvement
in glycemic control associated with periodontal therapy.
Among the set of thirteen periodontal treatment
studies that were not RCTs, eight reported a beneficial
effect on glycemic control (Williams and Mahan,
1960; Wolf, 1977; Miller et al, 1992; Seppala et al,
1993; Seppala and Ainamo, 1994; Iwamoto et al, 2001;
Faria-Almeida et al, 2006; Schara et al, 2006) and five
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did not (Smith et al, 1996; Westfelt et al, 1996; Christ-
gau et al, 1998; Promsudthi et al, 2005; Talbert et al,
2006). Only two of these studies had control or
comparison groups (Stewart et al, 2001; Promsudthi
et al, 2005). Like the RCTs there was marked variation
in the use of adjunctive antibiotics, with three of the five
studies that used systemic antibiotics reporting a ben-
eficial effect on glycemic control (Williams and Mahan,
1960; Miller et al, 1992; Iwamoto et al, 2001).
As shown in Table 3, there is marked heterogeneity in
the studies’ designs, conduct, length of follow-up, types
of participants, and periodontal treatment protocols.
The details of the variation in this body of literature
have been extensively described in several detailed
reviews (Grossi and Genco, 1998; Taylor, 1999; Janket
et al, 2005).
Additional evidence to support the effect of severe
periodontitis on increased risk for poorer glycemic
control comes from two longitudinal observational
studies. A longitudinal epidemiological study of the
Pima Indians in Arizona, USA (Taylor et al, 1996)
found subjects with type 2 diabetes in good to moderate
control and with severe periodontitis at baseline were
approximately six times more likely to have poor
glycemic control at approximately 2-years follow-up
than those without severe periodontitis at baseline. In
another observational study of 25 adults with type 2
diabetes, aged 58–77 years, Collin et al (1998) also
reported an association between advanced periodontal
disease and impaired metabolic control.
It is well recognized that poor glycemic control is a
major determinant for the development of the chronic
complications of diabetes. Results from the landmark
Diabetes Control and Complications Trial (type 1
diabetes) and the UK Prospective Diabetes Study
(type 2 diabetes) demonstrated that attaining and
maintaining good glycemic control could reduce the
risk for and slow the progression of microvascular
complications in patients with type 1 and type 2
diabetes (Anonymous, 1993, 1998a,b) (Diabetes Con-
trol and Complications Trial Research Group, 1993).
Additionally, the UKPDS observed a 16% reduction
(P = 0.052) in the risk of combined fatal or nonfatal
myocardial infarction and sudden death. Further
epidemiological analysis from the UKPDS showed a
continuous association between the risk of cardio-
vascular complications and glycemia; every percentage
point decrease in HbAlc (e.g., 9–8%), was associated
with 25% reduction in diabetes-related deaths, 7%
reduction in all-cause mortality, and 18% reduction in
combined fatal and nonfatal myocardial infarction
(Genuth et al, 2003).
There is emerging evidence from observational
studies regarding the association between periodontal
disease and the risk for diabetes complications.
Thorstensson et al (1996) studied 39 case-control pairs
of individuals with type 1 and type 2 diabetes for
6 years median follow-up time in Jönköping, Sweden.
In each pair the cases had severe alveolar bone loss
and controls had gingivitis or minor alveolar bone
loss. They found that cases were significantly more
likely to have prevalent proteinuria, and cardiovascu-
lar complications including stroke, transient ischemic
attacks, angina, myocardial infarction, and intermit-
tent claudication than controls at their follow-up
medical assessments.
Two recent reports from the on-going longitudinal
study of diabetes and its complications in the Gila River
Indian Community in Arizona, USA, conducted by the
National Institute of Diabetes and Digestive and Kidney
Diseases, address nephropathy and cardiovascular dis-
ease. Saremi et al (2005) studied a cohort of 628
individuals for a median follow-up time of 11 years.
Individuals with severe periodontal disease had 3.2 times
greater risk for cardio-renal mortality (i.e., ischemic
heart disease and diabetic nephropathy combined) than
those with no, mild, or moderate periodontal disease.
This estimate of significantly greater risk persisted while
controlling for several major risk factors of cardio-renal
mortality including: age, sex, diabetes duration, HbA1c,
body mass index (BMI), hypertension, blood glucose,
cholesterol, electrocardiographic abnormalities, macro-
albuminuria, and smoking.
In the second report Shultis et al (2007) investigated
the effect of periodontitis on risk for development overt
nephropathy (macroalbuminuria) and end-stage renal
disease (ESRD) in a group of 529 Gila River Indian
Community adults with type 2 diabetes. Their propor-
tional hazards models analyses, adjusted for age, sex,
diabetes duration, body mass index, and smoking,
indicated periodontitis and edentulism were significantly
associated with the risk of overt nephropathy and
ESRD. The incidence of macroalbuminura was 2.0, 2.1,
and 2.6 times greater in individuals with moderate or
severe periodontitis or in those who were edentulous,
respectively, than those with none/mild periodontitis.
The incidence of ESRD was also 2.3, 3.5, and 4.9 times
greater for individuals with moderate or severe perio-
dontitis or for those who were edentulous, respectively,
than those with none/mild periodontitis.
The clinical and epidemiological evidence reviewed
provides support for the concept that periodontal
infection contributes to poorer glycemic control and
the risk for diabetes complications in people with
diabetes mellitus. However, further rigorous, controlled
trials in diverse populations are warranted to firmly
establish that treating periodontal infections can be
influential in contributing to glycemic control manage-
ment and possibly to the reduction of the burden of
complications of diabetes mellitus.
Summary and conclusion
The evidence reviewed in this report supports previous
conclusions that diabetes is associated with increased
occurrence and progression of periodontitis and peri-
odontal infection is associated with poorer glycemic
control in people with diabetes. There is also evidence
emerging that gestational diabetes may adversely affect
periodontal health. Additionally, evidence is emerging
to suggest that periodontal disease is associated with
increased risk for diabetes complications. While treating
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periodontal infection in people with diabetes is clearly
an important component in maintaining oral health, it
may also have an important role in establishing and
maintaining glycemic control and possibly in delaying
the onset or progression of diabetes complications.
Further rigorous, systematic study in diverse popula-
tions is warranted to support existing evidence that
treating periodontal infections can be influential in
contributing to glycemic control management and
possibly to the reduction of the burden of complications
of diabetes mellitus.
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